Qualigen Therapeutics
QLGN
QLGN
7 hedge funds and large institutions have $2.2M invested in Qualigen Therapeutics in 2015 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 5 closing their positions.
Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
2
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$102K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BC
1
Broadfin Capital
New York
| $1.32M | 778,000 | – | – |
|
|
BBA
2
Baker Bros. Advisors
New York
| $680K | 400,000 | – | – |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $102K | 60,031 | +5,000 | +9% |
|
|
VKH
4
Virtu KCG Holdings
New York
| $64K | 37,500 | -2,916 | -7% |
|
|
TMC
5
Trellus Management Company
Delray Beach,
Florida
| $31K | 18,000 | -2,000 | -10% |
|
|
HCMT
6
Highland Capital Management (Texas)
Dallas,
Texas
| – | – | -150,000 | Closed |
|
7
Millennium Management
New York
| – | – | -95,022 | Closed |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| – | – | -9,805 | Closed |
|
9
UBS Group
Zurich,
Switzerland
| – | – | -2,574 | Closed |
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | – | -556 | Closed |
|
11
Morgan Stanley
New York
| $0 | 13 | +13 | New |
|
12
Citigroup
New York
| $0 | 125 | +125 | New |
|